Navigation Links
University launches iphone app for hepatitis treatment
Date:11/22/2011

The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C (HCV) patients with quick and easy access to the latest information about drug interactions.

Hepatitis C was first discovered in the 1980s when it became apparent that there was a new virus (not the already known hepatitis A or B) causing liver damage. Hepatitis C causes inflammation and swelling of the liver. It is estimated that over 170million individuals representing 3% of the world's population are chronically infected with the Hepatitis C virus (HCV). Statistically, as many people are infected with HCV as are with HIV.

Since its identification, drug treatment to eradicate the virus has advanced greatly, especially in the last few years. Two new drugs have recently been licensed for treatment of HCV, and there are more drugs in development.

HEP i-chart is based on the website (http://www.hep-druginteractions.org/) developed at the University by Professor David Back and Professor Saye Khoo which provides a comprehensive online guide to the interactions between anti-hepatitis drugs and other drugs. It is a tool that provides Hepatitis C patients and healthcare professionals with immediate access to up-to-date information on potential drug interactions between HCV drugs, and other drugs that the patient may be prescribed as well as over-the-counter, recreational or herbal medications.

Existing HCV drugs, newly licensed drugs and drugs in development can have interactions with each other and with other drugs which can impact on their effectiveness sometimes with serious consequences. For this reason, some drug combinations must not be used, whilst others must be given with caution, possibly requiring adjustment or monitoring.

Professor of Pharmacology, David Back, said: "We are delighted to launch with our partners KnowledgePoint360, MSD and Janssen- this new i-phone application that provides Hepatitis C patients and healthcare professionals with instant and easy access to information about HCV drug interactions which is relevant and reliable and up-to-date. This resource is especially important as new HCV drug treatments are approved and come into use."

Professor Graham Foster, President of the British Association for the Study of the Liver (BASL) said: "This new app, HEP i-chart, is a timely and much-needed resource for HCV patients as the number of new drugs which are available to treat Hepatitis C increases."


'/>"/>
Contact: Sarah Stamper
sarah.stamper@liv.ac.uk
01-517-943-044
University of Liverpool
Source:Eurekalert

Related medicine news :

1. Cervical smears can be humiliating and stressful, says new study from University of Leicester
2. University of Alaska science station nets $16 million award
3. University of Calgary researcher named Canadas Health Researcher of the Year
4. Wayne State University to study novel treatment for antibiotic-resistant bacteria
5. Ben-Gurion University of the Negev researchers achieve male fertility breakthrough
6. George Mason University research gives hope to women with deadliest breast cancer
7. University of Tennessee microbiologist to develop biofilter to clean-up toxic water
8. New University of Houston research addresses problem drinking among college students
9. University of Colorado Denver receives Grand Challenges Explorations funding
10. University Hospitals Case Medical Center neurosurgeons champion brain bypass in select patients
11. Michigan State University tackles health needs of an aging statewide population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... , ... The American Board of Quality Assurance and Utilization Review Physicians (ABQAURP) ... Health Care Quality and Management and Patient Safety. , It is with appreciation and ... also to the Health Care Quality and Patient Safety movements. Diplomates and Members lead ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... and the New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April ... , How will the new EU MDR language change the way manufacturers ...
(Date:3/23/2017)... ... , ... “Beyond and Back”: a true-life testimony of tragedy and the miraculous ... Bonetta Rose, a wife, mother and grandmother committed to sharing her many spiritual adventures ... Rose‘s new book presents actual events in the life of her family, which validate ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... the existence of God. “A Respectful Response To Atheist Manifesto” is the creation ... married to his wife, Nancy, for sixty years. He holds graduate degrees from ...
(Date:3/22/2017)... ... March 23, 2017 , ... Death anxiety is unconscious ... profession, author Joy Nugent was inspired to write the book titled “ As Good ... inward desire to make sense of what she was experiencing at the bedside of ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... , March 23, 2017 BioLineRx ... and immunology, announced today that it has acquired Agalimmune Ltd., ... Acquisition consideration consisted of a $6 million upfront payment, of ... BioLineRx shares. Additional future payments may be made based on ... ...
(Date:3/23/2017)... March 23, 2017 AbbVie, a global biopharmaceutical ... choreographer Julianne Hough is helping to raise ... the Know about ME in EndoMEtriosis . "   ... women to learn about and understand endometriosis, a disease ... and to address their symptoms with a healthcare professional. ...
(Date:3/23/2017)... -- During the "Nudging for Good" ... , My UV Patch, La Roche-Posay,s digital breakthrough ... ones, was awarded the Diamond Award by the ... "Nudging for Good" Award aims to honor brands ... to change behaviour and adopt a healthier and/or ...
Breaking Medicine Technology: